(1888 PressRelease) The company is also pushing to license its patented products in Japan, Taiwan and Malaysia.
Invivo Robotics (ISIN: CN2347660099), one of the pioneers in the rapidly emerging field of robotic-assisted minimally invasive surgery, is pleased to announce new clearances and provided an update on the status of its Invivo Robotics Surgical System (IRSS) staplers.
The Invivo Robotics Surgical System (IRSS) staplers are amongst the few devices of their type that provide wristed articulation technology that detects when instrument jaws are adequately closed on target tissue. The design enables control of stapling from the surgeon console, creating a more direct relationship between clinical decision-making and instrument action. Invivo Robotics has received clearance for stapler use on the Invivo Robotics Surgical System (IRSS) by various regulatory bodies in the United States and Europe.
“This is robotic-assisted technology at its best. The new robotic stapler allows for full surgeon control, with wristed functionality unlike other products in the market,” said Chen G. Gexin, MD, PhD, Chief Executive Officer for Invivo Robotics. “The instrument’s internal feedback gives the surgeon the certainty that the stapling was performed in the best conditions. Overall, it is a significant enhancement to the technology.”
The Invivo Robotics Surgical System (IRSS) Staplers are designed and intended for resection, transection and/or creation of anastomoses (surgical connections between vessels or tissues) in general, gynecologic and urologic surgery. Thoracic surgery is a new indication for the Invivo Robotics Surgical System (IRSS) Staplers with the availability of white staple reloads for thin tissue usage.
“The advancements we’ve made with the Invivo Robotics Surgical System (IRSS) Staplers further underscore our progress in offering a broad range of tools and resources to surgeons spanning several specialties, including general surgery,” said Chris Leung, Head of Global Product Development.”
About Invivo Robotics (ISIN: CN2347660099)
Invivo Robotics is one of the pioneers in the rapidly emerging field of robotic-assisted minimally invasive surgery. Invivo Robotics serves globally providing technology innovation across cardiac, thoracic, urology, gynecologic, colorectal, pediatric and general surgical disciplines. The Company’s surgical systems enables surgeons to operate minimally invasively. At Invivo Robotics, delivering our technology is just the beginning. The company is also committed to delivering the best customer experience. To ensure the customers gain the most utility from their Invivo Robotics systems, the firm offers a comprehensive training and education program and first-rate customer support. Invivo Robotics has strong financial backing of leading global investors.
http://www.invivo-robotics.com
